These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 27637804)
21. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. Oaks AW; Frankfurt M; Finkelstein DI; Sidhu A PLoS One; 2013; 8(4):e60378. PubMed ID: 23560093 [TBL] [Abstract][Full Text] [Related]
22. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease. Paumier KL; Sukoff Rizzo SJ; Berger Z; Chen Y; Gonzales C; Kaftan E; Li L; Lotarski S; Monaghan M; Shen W; Stolyar P; Vasilyev D; Zaleska M; D Hirst W; Dunlop J PLoS One; 2013; 8(8):e70274. PubMed ID: 23936403 [TBL] [Abstract][Full Text] [Related]
23. A53T-alpha-synuclein-overexpression in the mouse nigrostriatal pathway leads to early increase of 14-3-3 epsilon and late increase of GFAP. Kurz A; May C; Schmidt O; Müller T; Stephan C; Meyer HE; Gispert S; Auburger G; Marcus K J Neural Transm (Vienna); 2012 Mar; 119(3):297-312. PubMed ID: 21960009 [TBL] [Abstract][Full Text] [Related]
24. Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease. Zhang LF; Yu XL; Ji M; Liu SY; Wu XL; Wang YJ; Liu RT Food Funct; 2018 Dec; 9(12):6414-6426. PubMed ID: 30462117 [TBL] [Abstract][Full Text] [Related]
27. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Kuo YM; Li Z; Jiao Y; Gaborit N; Pani AK; Orrison BM; Bruneau BG; Giasson BI; Smeyne RJ; Gershon MD; Nussbaum RL Hum Mol Genet; 2010 May; 19(9):1633-50. PubMed ID: 20106867 [TBL] [Abstract][Full Text] [Related]
28. Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice. Okuda S; Uemura N; Sawamura M; Taguchi T; Ikuno M; Uemura MT; Yamakado H; Takahashi R Neurotherapeutics; 2022 Jan; 19(1):289-304. PubMed ID: 34935120 [TBL] [Abstract][Full Text] [Related]
29. Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease. Kuang S; Yang L; Rao Z; Zhong Z; Li J; Zhong H; Dai L; Tang X Can J Neurol Sci; 2018 Mar; 45(2):182-187. PubMed ID: 29506601 [TBL] [Abstract][Full Text] [Related]
30. Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice. Rothman SM; Griffioen KJ; Vranis N; Ladenheim B; Cong WN; Cadet JL; Haran J; Martin B; Mattson MP J Parkinsons Dis; 2013; 3(2):215-29. PubMed ID: 23938351 [TBL] [Abstract][Full Text] [Related]
31. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment. Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983 [TBL] [Abstract][Full Text] [Related]
32. Brain infusion of α-synuclein oligomers induces motor and non-motor Parkinson's disease-like symptoms in mice. Fortuna JTS; Gralle M; Beckman D; Neves FS; Diniz LP; Frost PS; Barros-Aragão F; Santos LE; Gonçalves RA; Romão L; Zamberlan DC; Soares FAA; Braga C; Foguel D; Gomes FCA; De Felice FG; Ferreira ST; Clarke JR; Figueiredo CP Behav Brain Res; 2017 Aug; 333():150-160. PubMed ID: 28668282 [TBL] [Abstract][Full Text] [Related]
34. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson's disease. Li Y; Niu M; Zhao A; Kang W; Chen Z; Luo N; Zhou L; Zhu X; Lu L; Liu J J Neuroinflammation; 2019 Dec; 16(1):263. PubMed ID: 31831012 [TBL] [Abstract][Full Text] [Related]
36. MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson's disease. Geng L; Gao W; Saiyin H; Li Y; Zeng Y; Zhang Z; Li X; Liu Z; Gao Q; An P; Jiang N; Yu X; Chen X; Li S; Chen L; Lu B; Li A; Chen G; Shen Y; Zhang H; Tian M; Zhang Z; Li J Mol Neurodegener; 2023 Dec; 18(1):94. PubMed ID: 38041169 [TBL] [Abstract][Full Text] [Related]
37. Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson's models. La Vitola P; Balducci C; Baroni M; Artioli L; Santamaria G; Castiglioni M; Cerovic M; Colombo L; Caldinelli L; Pollegioni L; Forloni G Neuropathol Appl Neurobiol; 2021 Feb; 47(1):43-60. PubMed ID: 32696999 [TBL] [Abstract][Full Text] [Related]